Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Cash flows from operating activities:
Net loss	$ (9,980,307)	$ (17,800,178)	$ (14,908,038)
Adjustments to reconcile net loss to net cash provided (used in) by operating activities:
Depreciation and amortization	2,220,185	2,528,815	2,032,459
Amortization of discounts, premiums and deferred cost	1,118,194	2,265,061	2,553,317
Share-based compensation	5,426,985	7,495,759	8,796,641
Deferred tax provision	0	(1,480,166)	610,033
Gain on lease termination	(9,225)	0	0
Gain on sale of reporting unit	(39,234)	0	0
Gain on sale of fixed assets	0	0	(303)
Financing fee and bank charges for note payable and advances on revolving credit line	0	0	3,775
Goodwill impairment loss	0	6,919,094	0
Lease cost	286,572	218,314	1,139
Legal fees paid out of proceeds from note payable	0	0	30,000
Change in fair value of contingent earnout	0	(92,000)	555,000
Change in fair value of derivative liabilities	725,600	(1,054,025)	132,000
Gain from timing difference on issuance of shares	0	(107,491)	0
Changes in assets and liabilities
Accounts receivable	1,036,587	(1,187,118)	634,448
Proceeds From Factoring Accounts Receivable	0	850,141	0
Prepaid expenses and other current assets	(147,602)	75,614	(321,593)
Contract asset (liability)	(109,498)	96,785	333,621
Lease liabilities	(269,518)	(185,261)	0
Accounts payable and accrued expenses	861,366	(807,791)	537,664
Net cash provided (used in) by operating activities	1,120,105	(2,264,447)	990,163
Cash flows from investing activities:
Acquisition of business, cash paid to seller	0	(485,739)	(250,000)
Sale of subsidiary, cash received from buyer	279,207	0	0
Cash from factoring	0	(411,975)	0
Acquisition of business, cash received from seller	0	475,000	0
Investment in captive insurance entity	(54,534)	0	0
Purchases of fixed assets	(3,317)	(18,271)	(89,282)
Net cash provided (used in) by investing activities	221,356	(440,985)	(339,282)
Cash flows from financing activities:
Proceeds from revolving credit line	1,374,919	325,000	300,000
Payment of debt issuance costs	(64,219)	(15,000)	0
Proceeds from issuance of preferred and common stock	12,052,704	126,000	625,000
Proceeds from note payable	0	1,200,000	1,470,000
Proceeds from exercise of stock options	0	0	12,000
Proceeds from stock offering related to uplisting	0	0	2,000,756
Preferred stock dividend	(119,277)	(118,152)	(100,516)
Repayment of convertible note payable – related party	(809,617)	0	(500,000)
Loss on induced conversion	0	300,000	0
Repayment of amounts due to seller	(730,000)	(280,000)	(471,003)
Repayment of notes payable	(2,621,764)	(1,642,471)	(1,364,137)
Net cash provided (used in) by financing activities	9,082,746	(104,623)	1,972,100
Net increase (decrease) in cash	10,424,207	(2,810,055)	2,622,981
Cash and restricted cash - beginning of period	1,830,841	4,640,896	2,017,915
Cash and restricted cash - end of period	12,255,048	1,830,841	4,640,896
Supplemental disclosures:
Cash paid for interest	794,361	994,449	912,965
Cash paid for income taxes	47,315	72,484	467,910
Summary of noncash activities:
Extinguishment of debt discount - derivative liabilities	0	171,128	0
Extinguishment of debt discount - debt issuance costs	0	8,034	0
Debt discount on note payable	0	28,000	500,000
Common shares issued for obligation to issue shares	0	0	533,750
Derivative liabilities incurred for note payable	0	421,000	692,000
Extinguishment of derivative liability	0	33,375	0
Gain on extinguishment of convertible note payable - related party	0	0	2,667,903
Adjustment to contingent consideration and customer relationships	0	0	275,000
Fair value adjustment recognized on issuance of common stock in Securities Purchase Agreement	0	0	93,000
Deferred issuance costs	0	0	59,300
Conversion of Series B preferred shares to common stock	0	0	1,805
Derecognition of lease liability	396,388	0	0
Derecognition of ROU asset	387,164	0	0
Partial Conversion Of Notes Payable
Summary of noncash activities:
Partial conversion of note payable	$ 0	$ 0	$ 160,000